Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01619553 · ClinicalTrials.gov registry record

Genetic Analysis of Keloids

A clinical trial of Keloid, sponsored by UConn Health.

Recruiting
Registry status
7,000
Enrollment target
1
Study location

NCT01619553 is a study of Keloid that is actively recruiting participants, run by UConn Health. The registered enrollment target is 7,000 participants, above the 1,269-participant average among 8 other Keloid trials with a reported enrollment target (452% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01619553, a study of Keloid, is actively recruiting participants, sponsored by UConn Health.

RECRUITING
Registry status
7,000 participants
Enrollment target
1
Study location

Study Summary

Keloids have a strong genetic component. The goal of this study is to identify genes and regulatory elements on chromosomes that are the cause for keloids or contribute to keloid scarring.

Conditions Studied

Study Locations (1)

Connecticut

  • University of Connecticut Health Center (UCHC) - Farmington

Trial Details

FieldValue
Enrollment Target 7,000 participants
Start Date 2009-04
Est. Completion 2025-12

Sponsor

UConn Health

178 total trials

What the Registry Record Tells You About NCT01619553

The ClinicalTrials.gov registry entry for NCT01619553 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 7,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,269-participant average among 8 other Keloid trials with a reported enrollment target (452% higher). The listed sponsor is UConn Health, which has 178 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Keloid appearing as the primary indexed condition, and to 0 interventions.

NCT01619553 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT01619553 about?

NCT01619553 is a clinical study titled "Genetic Analysis of Keloids". Keloids have a strong genetic component. The goal of this study is to identify genes and regulatory elements on chromosomes that are the cause for keloids or contribute to keloid scarring.

What is the current status of trial NCT01619553?

This trial is currently recruiting. The enrollment target is 7,000 participants. The study started on 2009-04. Estimated completion is 2025-12.

What conditions does trial NCT01619553 study?

This clinical trial studies the following conditions: Keloid.

Who is sponsoring clinical trial NCT01619553?

This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01619553 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Keloid

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.